We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
News

Baylor, TGen Collaborate on Personalized Cancer Treatment Options

Baylor, TGen Collaborate on Personalized Cancer Treatment Options
News

Baylor, TGen Collaborate on Personalized Cancer Treatment Options

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Baylor, TGen Collaborate on Personalized Cancer Treatment Options"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Baylor Research Institute (BRI) at Dallas and the Translational Genomics Research Institute (TGen) in Phoenix today announced an agreement to collaborate on early detection and treatment of cancers.

The partners will concentrate on three research areas: breast and other cancers associated with women's health; abdominal malignancies including pancreatic, colorectal, and liver cancers; and blood cancers including leukemia, lymphoma, and multiple myeloma.

They will provide the precision medicine services across Baylor Scott & White Health's 49 hospitals throughout Texas. Baylor Scott & White Health is non-profit healthcare system that was formed through the 2013 merger of Baylor Health Care System and Scott & White Healthcare.

"We will combine TGen's strengths in genomics and proteomics with BRI's strengths in metabolomics and immune-based approaches, initially focusing on genomic, molecular, and translational research for oncology," Robert Pryor, president, COO, and CMO of Baylor Scott & White Health, said in a statement.

Researchers will work in clinics and labs throughout the Baylor healthcare system as well as TGen facilities in Phoenix and Scottsdale, Arizona. A joint operations program will manage the collaboration from the Charles A. Sammons Cancer Center at the Baylor University Medical Center in Dallas.

The organizations said they will also collaborate in other research areas, such as infectious disease, cardiovascular health, diabetes, neurology, and metabolic disease.

Financial details of the collaboration were not disclosed.

Advertisement